Creative Medical Technology Holdings Provides Corporate Update

Continuing to Advance Regenerative Therapies for Diabetes and Chronic Lower Back Pain
Strong Financial Position with No Long-Term Debt 

PHOENIX, Nov. 15, 2023 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, today provided an update on recent business activities in connection with the filing of its Form 10-Q with the Securities and Exchange Commission.